Canid simplifies pediatricians' work by redesigning how the vaccination process works.
Canid has raised $10.0M in total funding. The most recent round was Series A. The last funding was announced in June 2025.
Canid's investors include Alumni Ventures, FJ Labs, Brooklyn Bridge Ventures, Telescope Partners, SeedToB Capital.
Canid is headquartered in New York, United States.
Canid simplifies pediatricians' work by redesigning how the vaccination process works.
Canid is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Canid — Funding & Investors." VCBacked, June 3, 2025, https://www.vcbacked.co/company/canid. Accessed September 9, 2026.
VCBacked. (2025). Canid — Funding & Investors. Retrieved September 9, 2026, from https://www.vcbacked.co/company/canid
{{cite web |title=Canid — Funding & Investors |url=https://www.vcbacked.co/company/canid |website=VCBacked |access-date=September 9, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated